SCHEMBL27346134

SCHEMBL27346134

Cc1cc(SN2CC3CN(C4CCOCC4)CC3C2)n(C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27346367 0.83 TGFBR1 (0.31) —
SCHEMBL27345085 0.78 — —
SCHEMBL30719506 0.75 MEN1 (0.33) —
SCHEMBL27346137 0.75 MEN1 (0.33) —
SCHEMBL27346188 0.74 ALDH1A1 (0.34) —
SCHEMBL26025987 0.70 OPRL1 (0.33) —
SCHEMBL27346398 0.69 SIGMAR1 (0.32) —
SCHEMBL27346440 0.69 PDE9A (0.30) —
SCHEMBL26065954 0.68 — —
SCHEMBL26066064 0.68 TLR9 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024015503-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2024-01-18 — — WO disclosed
Send feedback